Oxford Biomedica plc (LON:OXB – Get Free Report)’s stock price passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 421.03 ($5.27) and traded as high as GBX 427.50 ($5.35). Oxford Biomedica shares last traded at GBX 423 ($5.29), with a volume of 114,411 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Oxford Biomedica from GBX 250 ($3.13) to GBX 380 ($4.75) and gave the stock a “hold” rating in a research note on Tuesday, September 24th.
Check Out Our Latest Analysis on OXB
Oxford Biomedica Stock Down 0.5 %
About Oxford Biomedica
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Featured Articles
- Five stocks we like better than Oxford Biomedica
- How Investors Can Find the Best Cheap Dividend Stocks
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Basic Materials Stocks Investing
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.